The Leader
in Critical Biological
Material Management

Market Solutions

Fisher BioServices is the industry leader in the management of critical biological materials to support the advancement of cell therapy, GMP biologics, and population-based public health research.

Cell Therapy

Learn More

Public Health Research

Learn More

GMP Biologics Management

Learn More

Blog


Breakthroughs & Setbacks in Cancer Immunotherapies
  • April 13, 2016
  • Niveen M. Mulholland, Ph.D
  • Topic: Cell Therapy

When President Nixon declared a war on cancer in 1971, scientists and the general public were energized about the possibility of eliminating these costly and deadly diseases. In the decades following, however, many initially promising treatments failed to deliver expected results. Although the medical community has become more skilled at targeting treatments to specific cancers, cancer remains the second most common cause of death in the United States.

Supporting Services

Learning Center

Engaging content to enhance your knowledge of our services in action

Learn More

Join 8000 of your peers and subscribe to our blog for weekly updates on industry trends and new discoveries

feedback

 

x
feedback

 

x